SEATTLE, May 15, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, today announced that Canntab Therapeutics Ltd. (CSE:PILL) (CNSX:PILL) (PILL.CN) has engaged CFN Media to conduct a three month investor and market visibility program to begin on May 15, 2018.

“Canntab Therapeutics is focused on cannabis oral dosage formulations designed to standardize medical cannabis extracts from selective strains”, said Frank Lane, President of CFN Media. “In April, the company announced that it filed three additional U.S. patents and one international patent application, bringing its portfolio up to 11 patent applications around the world. We’re excited to be working with the company as they work to put the ‘medical’ back into ‘medical cannabis’ through specialized formulations.”

“We are excited to be working with CFN Media to create awareness for our company and products. CFN’s ability to help many companies attract a wider audience is a huge advantage to Canntab,” said Canntab CEO Jeff Renwick.

CFN Media will leverage its powerful content platform and extensive reach into mainstream and cannabis-focused investor audiences and media across North America to attract high-quality investors to Canntab Therapeutics Ltd. while elevating the company’s financial brand.

Learn how to become a CFN Media client company, brand or entrepreneur: http://www.cannabisfn.com/become-featured-company/

Download the CFN Media iOS mobile app to access the world of cannabis from the palm of your hand: https://itunes.apple.com/us/app/cannabisfn/id988009247?ls=1&mt=8

Or visit our homepage and enter your mobile number under the Apple App Store logo to receive a download link text on your iPhone: http://www.cannabisfn.com

About CFN Media

CFN Media (CannabisFN), the leading agency and financial media network dedicated to the worldwide cannabis industry, helps companies operating in the space attract investors, capital, and publicity. Private and public marijuana companies in the US and Canada rely on CFN Media to succeed in the capital markets.

About Canntab Therapeutics Ltd.

Canntab Therapeutics Limited is a Canadian cannabis oral dosage formulation company based in Markham Ontario, engaged in the research and development of advanced pharmaceutical grade formulations of cannabinoids. Canntab has developed in-house technology to deliver standardized medical cannabis extract from selective strains in a variety of extended/sustained release pharmaceutical dosages for therapeutic use. Simply put, Canntab's mission is to put the "Medical" into medicinal cannabis.

Contact:

Frank Lane

206-369-7050

[email protected]